• About
  • Meet The Team
  • Privacy Policy
Monday, March 8, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

Cellectis (CLLS) hires HR veteran as Executive Vice President, Chief Human Resources Officer

by Shan Zee
November 17, 2020
in Featured
Share on FacebookShare on Twitter

Cellectis (Nasdaq: CLLS), a biopharmaceutical firm, today confirmed the appointment of Kyung Nam-Wortman as Chief Human Resources Officer and Executive Vice President of Cellectis. Also joining the Company’s Executive Committee is Ms. Nam-Wortman, who will be based in the New York office of Cellectis.

Ms. Nam-Wortman will work closely with Dr. Choulika and the executive teams in her new position at Cellectis to ensure that the organization progresses the strategy through the recruiting and retaining of talented people. She will also focus on further cultivating and strengthening the diverse and multicultural community of Cellectis while maximizing the role of the human resource of the organization.

Ms. Nam-Wortman joins Cellectis from Achillion, where she worked as Senior VP, Head of HR, Head of IT, Facilities, and Internal Communications.  She was responsible for managing the strategic and organizational aspects of the above roles at Achillion.

Cellectis (Nasdaq: CLLS), a biopharmaceutical firm, today confirmed the appointment of Kyung Nam-Wortman as Chief Human Resources Officer and Executive Vice President of Cellectis. Also joining the Company’s Executive Committee is Ms. Nam-Wortman, who will be based in the New York office of Cellectis.

Ms. Nam-Wortman will work closely with Dr. Choulika and the executive teams in her new position at Cellectis to ensure that the organisation progresses the strategy through the recruiting and retaining of talented people. She will also focus on further cultivating and strengthening the diverse and multicultural community of Cellectis, while maximising the human resources role of the organisation.

Kyung Nam-Wortman joins Cellectis from Achillion, where she worked as Senior Vice President, Head of HR, Head of IT, Facilities and Internal Communications.  She was responsible for managing the strategic and organisational aspects of the above roles at Achillion.

Ms. Nam-Wortman served as VP and Head of Global Talent and Corporate Capacity at Zoetis prior to her time at Achillion, where she helped spin-off of the animal health business unit of Pfizer via its IPO and was key player for standing up the international talent management role of Zoetis to boost the development of the sector worldwide. She has held numerous major positions in HR with Pfizer’s company groups, branches, and domestic and global management functions.

Ms. Nam-Wortman has 14 years of expertise in the consultancy field focusing on strategic and organisational change management from Delta Consulting Group and IBM, in addition to her success with biotech/biopharma.

After completing her bachelor’s degree in marketing from the New York University Stern School of Business Ms. Nam-Wortman did her MS in Human Resources Management/Organizational Growth from the New School of Social Research’s

Cellectis (Nasdaq: CLLS), a biopharmaceutical firm, today confirmed the appointment of Kyung Nam-Wortman as Chief Human Resources Officer and Executive Vice President of Cellectis. Also joining the Company’s Executive Committee is Ms. Nam-Wortman, who will be based in the New York office of Cellectis.

Ms. Nam-Wortman will work closely with Dr. Choulika and the executive teams in her new position at Cellectis to ensure that the organization progresses the strategy through the recruiting and retaining of talented people. She will also focus on further cultivating and strengthening the diverse and multicultural community of Cellectis while maximizing the role of the human resource of the organization.

Ms. Nam-Wortman joins Cellectis from Achillion, where she worked as Senior Vice President, Head of HR, Head of IT, Facilities, and Internal Communications.  She was responsible for managing the strategic and organizational aspects of the above roles at Achillion.

Kyung Nam-Wortman served as VP and Head of Global Talent and Corporate Capacity at Zoetis prior to her time at Achillion, where she helped spin-off of the animal health business unit of Pfizer via its IPO and was a key player for standing up the international talent management role of Zoetis to boost the development of the sector worldwide.

Ms. Nam-Wortman has 14 years of expertise in the consultancy field focusing on strategic and organizational change management from Delta Consulting Group and IBM, in addition to her success with biotech/biopharma.

After completing her bachelor’s degree in marketing from the New York University SternSchool of Business Ms. Nam-Wortman did her MS in Human ResourcesManagement/Organizational Growth from the New School of Social Research’s.

MS. Nam-Wortman served as VP and Head of Global Talent and Corporate Capacity at Zoetis prior to her time at Achillion, where she helped spin-off the animal health business unit of Pfizer via its IPO and was a key player for standing up the international talent management role of Zoetis to boost the development of the sector worldwide. She has held numerous major positions in HR with Pfizer’s company groups, branches, and domestic and global management functions.

Ms. Nam-Wortman has 14 years of expertise in the consultancy field focusing on strategic and organizational change management from Delta Consulting Group and IBM, in addition to her success with biotech/biopharma.

After completing her bachelor’s degree in marketing from the New York University Stern School of Business Ms. Nam-Wortman did her MS in Human Resources Management/Organizational Growth from the New School of Social Research’s.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: CellectisCellectis stockCLLSKyung Nam-WortmanNasdaq: CLLS

Related Posts

Marinus Pharmaceuticals (NASDAQ: MRNS) Is Popping Today. Here’s Why
Featured

Apple (AAPL) or Alphabet (GOOGL): Which is the Better Stock Pick?

March 1, 2021
ASML Holding (NASDAQ: ASML) Announces 2020 Q3 Results
Featured

What dragged Vistra Corp (VST) about 25% lower?

February 27, 2021
High Flying Plasma Pharmaceuticals as FDA Approves Plasma-based COVID-19 Treatment
Featured

Three Top Coronavirus Stocks to Buy Anytime Soon

February 27, 2021
Tesla Inc. (NASDAQ: TSLA) Reportedly Discuss Nickel Supply Deal With Top Miner BHP
Featured

AMC Entertainment (AMC) Avoids Bankruptcy as Shares Pop Up

January 27, 2021
Top 3 Health Care Stocks that can attract investors in 2021
Featured

Top 3 Health Care Stocks that can attract investors in 2021

January 27, 2021
Sunworks (NASDAQ: SUNW) Stock Is Soaring Today. Here’s Why
Featured

Overstock.com (OSTK) Set to Convert its blockchain-based subsidiary to a limited partnership “Fund”

January 27, 2021
Next Post
7 Best Stocks In Internet Content Information Industry

Market Movers: What changed for these 45 stocks while you were sleeping

Early Morning Vibes: Top 4 Stocks To Buy Right Now

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Hasnain R
March 3, 2021
0

US stock indices closed with growth on Monday. The last week rally in US government bond yields stalled, easing investors'...

Read more

The fundamentals of KemPharm Inc. (KMPH) lend themselves to long-term investors

Why IBIO Inc [IBIO] is the Best Covid-19 Vaccine Stock to Bet On
by Hasnain R
March 3, 2021
0

KemPharm, Inc. (NASDAQ: KMPH)has performed -15.80% so far this year, while over the last seven days it has performed -4.8%....

Read more

Look Out for these Fintech Stocks in 2021

The Three Top Financial Stocks for Investment
by Zoha Fatim
March 1, 2021
0

Fintech stocks are a broad category of stocks consist of stocks which are part technology and part finance. Fintech stock...

Read more

SOS Limited (SOS) Stock Surged 18% In After Hours Trading. Here Is The Reason

Is Consumer Portfolio Services (NASDAQ: CPSS) A Good Stock To Buy?
by Shan Zee
March 2, 2021
0

The emergency rescue services technology company SOS Limited (SOS) saw its shares’ price rising 18.39% in trading after the ring...

Read more

Early Morning Vibes: Don’t Miss On These 4 Growth Stocks

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Hasnain R
March 1, 2021
0

In the recent times, Aviation stocks have suffered a serious crash. Covid-19 shut down the entire business. But US aviation stocks,...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.